Frequently asked questions about adverse drug reactions of methylphenidate

Ida M. Heerfordt*, Henrik Horwitz

*Corresponding author af dette arbejde

Abstract

This article addresses frequently asked questions about the adverse drug reactions associated with methylphenidate treatment. Methylphenidate is a central nervous system stimulant used primarily for the treatment of attention-deficit/hyperactivity disorder. It utilizes insights from the combined knowledge of pharmacists and physicians who advise healthcare professionals in the Capital Region of Denmark on patient-specific medication queries. The article provides an overview of the clinical challenges and safety considerations associated with methylphenidate use, integrating empirical data and clinical expertise to facilitate informed decision-making by practitioners.

OriginalsprogEngelsk
TidsskriftAdverse Drug Reaction Bulletin
Vol/bind345
Udgave nummer1
Sider (fra-til)1339-1342
Antal sider4
ISSN0044-6394
DOI
StatusUdgivet - 1 apr. 2024

Fingeraftryk

Dyk ned i forskningsemnerne om 'Frequently asked questions about adverse drug reactions of methylphenidate'. Sammen danner de et unikt fingeraftryk.

Citationsformater